BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 12, 2025
See today's BioWorld
Home
» Other news to note for Sept. 14, 2020
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 14, 2020
Sep. 14, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ABL, Accord, Acelrx, Aimmune, Arctoris, Astrazeneca, Biogen, Daiichi Sankyo, Evotec, Glycot, Hifibio, J&J, Keros, Lava, Marinus, Medigen, Molecular Partners, Moleculin, Molteni, Navire, Navrogen, Nestle, Neuraxpharm, Orexo, Pascal, Pfizer, Reveragen, Santhera, Sorrento, S?rse, Springworks, Starpharma, Syntekabio Takeda, Talaris, Tikomed, Vaxess.
BioWorld
Briefs
Other news to note
Coronavirus